Get started
Author

Andargachew Kumsa

Observed names: A. Kumsa, Andargachew Kumsa Erena
ORCID: 0000-0003-1245-7676
Observed ORCID: 0000-0003-1245-7676
OpenAlex ID: A5065464487
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
2022 · Catherine Hewison, Uzma Khan, et al. · Clinical Infectious Diseases · 56
PDF
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
2020 · Molly F. Franke, Palwasha Khan, et al. · American Journal of Respiratory and Critical Care Medicine · 56
The Burden of HIV/AIDS in Ethiopia from 1990 to 2016: Evidence from the Global Burden of Diseases 2016 Study
1970 · Amare Deribew, Sibhatu Biadgilign, et al. · Ethiopian Journal of Health Sciences · 52
PDF
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
2022 · Helena Huerga, Uzma Khan, et al. · Clinical Infectious Diseases · 41
PDF
Spatial codistribution of HIV, tuberculosis and malaria in Ethiopia
2022 · Kefyalew Addis Alene, Ahmed Elagali, et al. · BMJ Global Health · 40
PDF
Tuberculosis Burden in Ethiopia from 1990 to 2016: Evidence from the Global Burden of Diseases 2016 Study
1970 · Amare Deribew, Kebede Deribe, et al. · Ethiopian Journal of Health Sciences · 40
PDF
Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study
2019 · Teklu Molie, Zelalem Teklemariam, et al. · BMC Infectious Diseases · 22
PDF
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis
2019 · Kwonjune J Seung, Palwasha Khan, et al. · Clinical Infectious Diseases · 21
Mapping tuberculosis prevalence in Ethiopia using geospatial meta-analysis
2023 · Kefyalew Addis Alene, Andre Python, et al. · International Journal of Epidemiology · 20
PDF
Setting up pharmacovigilance based on available endTB Project data for bedaquiline
2020 · N. Lachenal, C. Hewison, et al. · The International Journal of Tuberculosis and Lung Disease · 11
Second-line drug resistance among multidrug-resistant tuberculosis patients in Ethiopia: A laboratory-based surveillance
2025 · Getu Diriba, Ayinalem Alemu, et al. · Journal of Global Antimicrobial Resistance · 8
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
2023 · Sara M Sauer, Carole D Mitnick, et al. · Clinical Infectious Diseases · 8
PDF
Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia
2025 · Getu Diriba, Hilina Mollalign, et al. · Communications Medicine · 5
PDF
Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling
2025 · Stephanie Law, Isabel Fulcher, et al. · Clinical Infectious Diseases · 5
PDF
Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study
2024 · Lelisa Fekadu Assebe, Andargachew Kumsa Erena, et al. · Cost Effectiveness and Resource Allocation · 5
Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends
2024 · E. Tesema, M. Biru, et al. · PLoS ONE · 4
Mapping leprosy in Ethiopia: Capture and analysis of district and health facility data to identify and map high leprosy burden districts
2023 · Lelisa Fekadu, Saba M. Lambert, et al. · Leprosy Review · 4
PDF
Assessment of national tuberculosis and HIV collaborative program implementation status in health care settings of Ethiopia.
2017 · Wudinesh Belete, Minilik Demissie, et al. · PubMed · 1
Comparative Effectiveness of Three Linezolid Management Strategies for Peripheral Neuropathy During Multidrug- or Rifampicin-Resistant Tuberculosis Treatment: A Target Trial Emulation
2026 · Matthew Romo*, Malik Adenov, et al. · Epidemiology
Comparison of 3 Linezolid Management Strategies for Peripheral Neuropathy in Multidrug- or Rifampicin-Resistant Tuberculosis Treatment: A Target Trial Emulation
2026 · Matthew Romo, Allison LaHood, et al. · Clinical Infectious Diseases
Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation
2026 · Matthew L Romo, Allison LaHood, et al. · medRxiv
Results of a National Tuberculosis Screening Initiative to detect undiagnosed tuberculosis cases in Ethiopia (2024)
2026 · Taye Letta Janfa, Kelemework Adane, et al. · Global Health Journal
Effect of Drought on Tuberculosis (TB) in Ethiopia: A case study from Borena and Shebelle Zones.
2025 · Yirgalem Shibiru Baruda, Andargachew Kumsa Erena, et al. · Research Square
PDF
Quantifying undetected tuberculosis in Ethiopia using a novel geospatial modelling approach
2025 · Haileab Fekadu Wolde, Archie C. A. Clements, et al. · Scientific Reports
PDF
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up
2023 · Sara M. Sauer, Carole D. Mitnick, et al. · medRxiv
PDF
Works count: 26
Citation count: 399
H-index: 10
I10-index: 10
Year
Topic
Type